First Time Loading...

Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 7.88 USD -0.88% Market Closed
Updated: May 8, 2024

Arcutis Biotherapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcutis Biotherapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Cash from Operating Activities
-$247.1m
CAGR 3-Years
-30%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.8B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
24%

See Also

What is Arcutis Biotherapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-247.1m USD

Based on the financial report for Dec 31, 2023, Arcutis Biotherapeutics Inc's Cash from Operating Activities amounts to -247.1m USD.

What is Arcutis Biotherapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-77%

Over the last year, the Cash from Operating Activities growth was 4%. The average annual Cash from Operating Activities growth rates for Arcutis Biotherapeutics Inc have been -30% over the past three years , -77% over the past five years .